The Fund may be susceptible to an increased risk of loss, including losses due to adverse events that affect the Funds investments more than the market as a whole, to the extent that the Funds investments are concentrated in the securities and/or other assets of a particular issuer or issuers, country, group of countries, region, market, industry, group of industries, sector, market segment or asset class
Gastrointestinal symptoms represent the most common adverse effects, including nausea, vomiting, diarrhoea, and constipation
Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells
Circulation 136 , 11141122 (2017)
Dosing Protocol Considerations No standardized, peer-reviewed protocol exists for combining Retatrutide and Tesamorelin